Citadel Advisors
LEGN icon

Citadel Advisors’s Legend Biotech LEGN Stock Holding History

Citadel Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Buy
96,300
+25,100
+35% +$479K ﹤0.01% 6387
2025
Q4 		$1.55M Buy
71,200
+25,200
+55% +$722K ﹤0.01% 6441
2025
Q3 		$1.5M Buy
46,000
+6,200
+16% +$229K ﹤0.01% 6678
2025
Q2 		$1.41M Buy
39,800
+22,100
+125% +$716K ﹤0.01% 6382
2025
Q1 		$601K Sell
17,700
-10,400
-37% -$373K ﹤0.01% 8083
2024
Q4 		$914K Buy
28,100
+7,800
+38% +$323K ﹤0.01% 7223
2024
Q3 		$989K Sell
20,300
-16,700
-45% -$890K ﹤0.01% 6884
2024
Q2 		$1.64M Sell
37,000
-43,400
-54% -$2M ﹤0.01% 5687
2024
Q1 		$4.51M Buy
80,400
+62,300
+344% +$3.76M ﹤0.01% 4102
2023
Q4 		$1.09M Buy
18,100
+6,100
+51% +$387K ﹤0.01% 6498
2023
Q3 		$806K Buy
12,000
+7,600
+173% +$528K ﹤0.01% 7018
2023
Q2 		$304K Sell
4,400
-1,200
-21% -$78.4K ﹤0.01% 9022
2023
Q1 		$270K Sell
5,600
-12,000
-68% -$587K ﹤0.01% 9591
2022
Q4 		$879K Sell
17,600
-4,000
-19% -$194K ﹤0.01% 7056
2022
Q3 		$881K Sell
21,600
-7,200
-25% -$338K ﹤0.01% 7266
2022
Q2 		$1.58M Buy
28,800
+100
+0.3% +$4.22K ﹤0.01% 6032
2022
Q1 		$1.04M Buy
28,700
+21,100
+278% +$834K ﹤0.01% 7591
2021
Q4 		$354K Buy
7,600
+2,200
+41% +$112K ﹤0.01% 10539
2021
Q3 		$273K Sell
5,400
-17,800
-77% -$741K ﹤0.01% 11260
2021
Q2 		$952K Buy
+23,200
New +$789K ﹤0.01% 8491

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors's LEGN Position: Q1 2026 in Review

Citadel Advisors increased its Legend Biotech (LEGN) stake by 190% in Q1 2026, buying an estimated $6.46M and bringing the position to 516,980 shares worth $9.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3351.

Citadel Advisors first reported a position in LEGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $94.5M in Q4 2024. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Citadel Advisors held 516,980 shares of Legend Biotech worth $9.35M as of Q1 2026.
  • Citadel Advisors bought 338,940 Legend Biotech shares in Q1 2026, an estimated $6.46M.
  • Legend Biotech made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3351 holding.
  • Citadel Advisors first reported a position in Legend Biotech in Q2 2020 and has held it in 24 quarters since.
  • Citadel Advisors's Legend Biotech position peaked at $94.5M in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.